Yanni Amalia E, Margaritis Eleutherios, Liarakos Nikolaos, Pantopoulou Alkisti, Poulakou Maria, Kostakis Maria, Perrea Despoina, Kostakis Alkis
Department of Science of Dietetics and Nutrition, Harokopio University of Athens,Athens, Greece.
Vasc Health Risk Manag. 2008;4(2):437-41. doi: 10.2147/vhrm.s2433.
To study the effect of oral administration of a nitric oxide (NO) donor L-arginine (L-Arg), a NO synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME) and an inhibitor of xanthine oxidase, allopurinol (Allo), on serum NO concentration and catalase activity after intestinal ischemia/reperfusion (I/R) in rats.
Male Wistar rats receivedper os L-Arg (800 mg/kg) or L-NAME (50 mg/kg) or Allo (100 mg/kg) 24 hrs, 12 hrs and 1 hr before underwent 1 hr occlusion of superior mesenteric artery followed by 1 hr of reperfusion (L-Arg(IR1), L-NAME(IR1) and Allo(IR1) respectively) or 1 hr occlusion followed by 8 hrs of reperfusion (L-Arg(IR8), L-NAME(IR8) and Allo(IR8) respectively). There was one group underwent 1 hr occlusion (I), a group underwent 1 hr occlusion followed by 1 hr reperfusion (IR1), a group subjected to 1 hr occlusion followed by 8 hrs of reperfusion (IR8) and a last group that served as control (C). Serum NO concentration and catalase activity were measured.
After 1 hr of reperfusion serum NO concentration was elevated in IR1 and L-Arg(IR1) groups compared with group C but not in L-NAME(IR1) and Allo(IR1) group. Catalase activity was enhanced in L-NAME(IR1) group. Interestingly, serum NO concentration was increased after 8 hrs of reperfusion in all groups (IR8, L-Arg(IR8), L-NAME(IR8) and Allo(IR8)) compared with control while catalase activity did not show significant difference in any group.
The results of the present study show that NO concentration is elevated in serum after intestinal I/R and the elevation sustained after administration of L-Arg but not after administration of L-NAME or Allo after 1 hr reperfusion. However, after 8 hrs of reperfusion NO concentration was increased in all groups studied, focusing attention on its possible important role in a complicated situation such as intestinal I/R that involves intestine and other organs. Serum catalase activity does not seem to be affected by per os supplementation of L-Arg or Allo in intestinal I/R.
研究口服一氧化氮(NO)供体L-精氨酸(L-Arg)、NO合酶抑制剂NG-硝基-L-精氨酸甲酯(L-NAME)以及黄嘌呤氧化酶抑制剂别嘌呤醇(Allo)对大鼠肠缺血/再灌注(I/R)后血清NO浓度和过氧化氢酶活性的影响。
雄性Wistar大鼠在肠系膜上动脉阻断1小时后再灌注1小时(分别为L-Arg(IR1)、L-NAME(IR1)和Allo(IR1)组)或阻断1小时后再灌注8小时(分别为L-Arg(IR8)、L-NAME(IR8)和Allo(IR8)组)前24小时、12小时和1小时经口给予L-Arg(800mg/kg)或L-NAME(50mg/kg)或Allo(100mg/kg)。有一组进行1小时阻断(I组),一组进行1小时阻断后再灌注1小时(IR1组),一组进行1小时阻断后再灌注8小时(IR8组),最后一组作为对照组(C组)。测定血清NO浓度和过氧化氢酶活性。
再灌注1小时后,IR1组和L-Arg(IR1)组血清NO浓度较C组升高,但L-NAME(IR1)组和Allo(IR1)组未升高。L-NAME(IR1)组过氧化氢酶活性增强。有趣的是,与对照组相比,所有组(IR8、L-Arg(IR8)、L-NAME(IR8)和Allo(IR8))再灌注8小时后血清NO浓度均升高,而过氧化氢酶活性在任何组中均无显著差异。
本研究结果表明,肠I/R后血清NO浓度升高,给予L-Arg后升高持续存在,但再灌注1小时后给予L-NAME或Allo则不然。然而,再灌注8小时后,所有研究组的NO浓度均升高,这使人们关注其在涉及肠道和其他器官的复杂情况如肠I/R中可能的重要作用。在肠I/R中,经口补充L-Arg或Allo似乎不影响血清过氧化氢酶活性。